Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes
Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Maria Domenica Cappellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Gianluigi Reda(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Nicola Martinelli(University of Verona), Alberto Bosi(Azienda Ospedaliero-Universitaria Careggi), Oliviero Olivieri(University of Verona), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Lorena Duca(University of Milan), Alessandro Sanna(Agence Régionale de Santé Nouvelle-Aquitaine), Natascia Campostrini(University of Verona), Michela Corbella(University of Verona), Domenico Girelli(University of Verona)
Cited by 136
Related Papers
(untitled)
|Edinburgh Research Explorer (University of Edinburgh)|0|2.3k
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
|Journal of Clinical Oncology|2009|963
Thalassaemia
|The Lancet|2017|763